Radiation Oncology Journal
- Volume 18 Issue 4
- /
- Pages.244-250
- /
- 2000
- /
- 2234-1900(pISSN)
- /
- 2234-3156(eISSN)
Neoadjuvant Chemotherapy and Radiotherapy in Locally Advanced Hypopharyngeal Cancer
국소 진행된 하인두암의 선행 항암화학요법 후 방사선치료
- Kim Suzy (Department of Therapeutic Radiology, Internal Medicine, Seoul National University College of Medicine) ;
-
Wu Hong-Gyun
(Department of Therapeutic Radiology, Internal Medicine, Seoul National University College of Medicine) ;
-
Heo Dae-Seog
(Department of Therapeutic Radiology, Internal Medicine, Seoul National University College of Medicine) ;
-
Park Charn I1
(Instisute of Radiation Medicine, Medical Research Center, Seoul National University)
- 김수지 (서울대학교 의과대학 치료방사선과학교실) ;
-
우홍균
(서울대학교 의과대학 치료방사선과학교실) ;
-
허대석
(서울대학교 의과대학 내과학교실) ;
-
박찬일
(서울대학교 의과대학 치료방사선과학교실)
- Published : 2000.12.01
Abstract
Purpose : To see the relationship between the response to chemotherapy and the final outcome of neoadiuvant chemotherapy and radiotherapy in patients with mocanry advanced hypopharyngeal cancer. Methods and Materials :A retrospective analysis was done for thirty-two patients with locally advanced hypopharyngeal cancer treated in the Seoul National University Hospital with neoadiuvant chemotherapy and radiotherapy from August 1979 to July 1997. The patients were treated with Co-60 teletherapy unit or 4MV or 6MV photon beam produced by linear accelerator. Daily fractionation was 1.75 to 2 Gy, delivered five times a week. Total dose ranged from 60.8 Gy to 73.8 Gy. Twenty-nine patients received continuous infusion of cisplatin and 5-FU. Other patients were treated with cisplatin combined with bleomycin or vinblastin. Twenty-four (75
목적 : 국소 진행된 하인두암에서 선행 항암화학요법과 방사선치료를 시행했을 때 결과와 각 치료법에 대한 반응이 생존율에 미치는 영향을 알아보고자 본 연구를 시행하였다. 대상 및 방법 :국소 진행된 하인두암으로 진단받고 선행 항암화학요법과 방사선치료를 받은 32명의 환자를 대상으로 후향적 분석을 실시하였다. 방사선치료는 일일 선량 1.75